학술논문

Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment
Document Type
article
Source
Subject
Biological Psychology
Psychology
Alzheimer's Disease
Brain Disorders
Acquired Cognitive Impairment
Dementia
Neurosciences
Neurodegenerative
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Aging
Aetiology
2.1 Biological and endogenous factors
Neurological
Aged
Amygdala
Atrophy
Brain
Cognitive Dysfunction
Entorhinal Cortex
Female
Hippocampus
Humans
Image Processing
Computer-Assisted
Magnetic Resonance Imaging
Male
Entorhinal cortex
Transentorhinal cortex
Mild cognitive impairment
Braak staging
Cortical thickness
Shape analysis
Longitudinal analysis
Alzheimer's Disease Neuroimaging Initiative
Biological psychology
Clinical and health psychology
Language
Abstract
This study examines the atrophy rates of subjects with mild cognitive impairment (MCI) compared to controls in four regions within the medial temporal lobe: the transentorhinal cortex (TEC), entorhinal cortex (ERC), hippocampus, and amygdala. These regions were manually segmented and then corrected for undesirable longitudinal variability via Large Deformation Diffeomorphic Metric Mapping (LDDMM) based longitudinal diffeomorphometry. Diffeomorphometry techniques were used to compare thickness measurements in the TEC with the ERC. There were more significant changes in thickness atrophy rate in the TEC than medial regions of the entorhinal cortex. Volume measures were also calculated for all four regions. Classifiers were constructed using linear discriminant analysis to demonstrate that average thickness and atrophy rate of TEC together was the most discriminating measure compared to the thickness and volume measures in the areas examined, in differentiating MCI from controls. These findings are consistent with autopsy findings demonstrating that initial neuronal changes are found in TEC before spreading more medially in the ERC and to other regions in the medial temporal lobe. These findings suggest that the TEC thickness could serve as a biomarker for Alzheimer's disease in the prodromal phase of the disease.